Regional Sites Contact Us ORAL DOSE BIOLOGICS SPECIALTY CLINICAL SUPPLY CONSUMER EXPERT CONTENT LOCATIONS ABOUT US CAREERS Home » Expert Content » Inhalation EXPERT CONTENT Downloadable expert content covering integrated, tailored solutions to accelerate your path to market. VISIT OUR YOUTUBE CHANNEL BROWSE BY SITES: BIOLOGICS CLINICAL SUPPLY SERVICES CONSUMER HEALTH TOPIC: VIEW ALL DEVELOPMENT & BIOAVAILABILITY DOSE FORM DESIGN ORAL TECHNOLOGIES SOFTGEL TECHNOLOGIES ORAL MANUFACTURING SMALL MOLECULE ANALYTICAL INHALATION SMALL MOLECULE INJECTABLE TYPE: VIEW ALL ARTICLE BROCHURE CASE STUDY EBOOK EXECUTIVE SUMMARY INFOGRAPHIC OFFERING FACT SHEET VIDEO WEBINARS Inhalation-Nasal Delivery Technology, Quality by Design Processes and Outsourcing Considerations Catalent leverages decades of experience in the development, evaluation and manufacture of inhalation products to advance and accelerate molecules, from early development through commercial manufacturing. Article: Industry Trend: Examining the Emergence of Unit- & Bi-Dose Nasal Sprays Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or… Orally Inhaled & Nasal Drug Delivery – An Evolving Pipeline Creating New Opportunities Catalent’s Carla Vozone discusses the significant inhalation trends including those in larger molecules and novel indications. Reducing Inhalation Burden Through High-Dose, Carrier-Free Spray Dry Powders Explore how spray dried particles provide an attractive, carrier-free option for highly dispersed delivery of API to deep lung regions. Industry Trend: Examining the Emergence of Unit- & Bi-Dose Nasal Sprays Summary: Molecules that are limited by a slow onset of action, a suboptimal side-effect profile, or a complicated administration process, may be good candidates for adaptation to a unit- or… Catalent’s Expanded Inhalation Offering Summary: Catalent expands its inhalation platform through the acquisition of a Boston-area facility, providing spray drying, powder encapsulation and blister packaging for Dry Powder Inhaler (DPI) capsules. Quality by design-Considerations for Inhalation Product Development This article discusses how quality by design (QbD) can be built into inhalation product development to ensure a drug and device are safe and effective. Strategies for Flexible Manufacturing Summary: Pharmaceutical and biotechnology companies approach external development and manufacturing partners for solutions for their product’s specific needs. New products are increasingly… All Offerings Summary: Catalyst + Talent. Our name combines these ideas. From drug and biologic development to delivery technologies and supply solutions, we are the catalyst for your… Regulatory Support Summary: Our regulatory team completes over 150 agency submissions each year, supporting all stages of the product lifecycle. We assign a dedicated… How to Effectively Work with a Development Partner – From a Consultant Standpoint Summary: Determining a client’s primary goal is critical to guiding them through the development of their asset. Three experienced industry colleagues recently presented on the latest tips… Inhalation Capabilities | Why Catalent? Summary: Catalent combines decades of project with all pulmonary dosage forms including pMDIs, DPIs, nasal sprays and solutions/suspensions for inhalation. Speed is delivered by… Reliably Supplied | Why Catalent? Summary: We have the technology and expertise to take your product from design, to clinical trial, to plant, to pharmacy. Our global network of facilities can provide scalable, cost-effective… Catalent in 30 Seconds Summary: With over 80 years serving the industry, Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products…. Optimal Drug Delivery Technologies. Better Treatments. Summary: We are your catalyst for creating better treatments. Our deep expertise in drug development, delivery and supply can help improve the bioavailability of your compound, enhance therapeutic profiles… Catalent Corporate Overview Summary: Catalent is the global leader in development, delivery, and supply for pharmaceuticals, biologics, and consumer health products. Integrated analytical and clinical supply services support to… Unlock Your Molecules Potential with Catalent Summary: Your molecule has so much potential, we share the passion to unlock it through extensive expertise and superior formulation technologies. Learn how we have optimized thousands… Bring Pharma, Biopharma and Consumer Health Products to Market with Catalent Summary: A short video on how Catalent can help you develop, deliver, supply better treatments. Whether it is Pharmaceuticals, Biopharmaceuticals, Over-the-Counter, Nutritionals or Beauty Care and Cosmetics, we can… Dry Powder Inhaler (DPI) Services at Catalent Summary: Catalent Inhalation provides flexible development and manufacturing solutions for Dry Powder Inhalers (DPIs). Metered Dose Inhaler (MDI) Services at Catalent Summary: Catalent Inhalation provides state-of-the-art development and manufacturing solutions for Metered Dose Inhalers (MDIs). Nasal Spray Manufacture at Catalent Summary: Catalent Inhalation provides robust development and manufacturing solutions for nasal sprays. Career Development at Catalent Summary: Catalent offers employees numerous opportunities for development and career progression. Hear more about what our team has to say about how Catalent supports their… Inhalation Capabilities Sheet Summary: Learn about the end-to-end capabilities of Catalent’s inhalation network, supporting the development and manufacture of formulations delivered by Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs) and unit- or bi-dose nasal sprays. Extractables & Leachables: Understanding Container and Device Interactions Summary: It is vital that drug products reach patients uncontaminated and unadulterated by their packaging. Extractables and leachables (E&L) are especially of concern for liquid injectable… Overcoming Challenges In Generic pMDI Development Define key aspects of product performance which must be met when developing a generic pMDI. The Medicine Maker – Deep Breaths and Dry Powder Explore the challenges with delivering drugs less invasively. The Medicine Maker – Delivering Change The future of non-invasive delivery technologies for large molecules. Expert Content Subscribe Investors Careers Contact Us Site Map Follow Us. Share Us. By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy | Privacy Shield Statement | Cookies Settings. Copyright 2021, Catalent, Inc - All Rights Reserved Terms Modern Slavery Statement This Website Uses Cookies By using this website you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy. Accept All Cookies Cookies Settings